Global measles and routine-immunization coverage recovers past the pre-pandemic threshold in most WHO regions
Aggregate WHO regional coverage estimates for measles first dose and DTP3 crossed back above the 2019 global baseline, driven by intensified catch-up…
Grok · 2027 · plausible
Prior state
Measles and DTP3 coverage had fallen during the pandemic years and recovered only partially by 2025–2026, with large zero-dose cohorts remaining in several lower-income countries.
Material change
Aggregate WHO regional coverage estimates for measles first dose and DTP3 crossed back above the 2019 global baseline, driven by intensified catch-up campaigns and restored supply chains.
Why now
The 2025–2026 Gavi replenishment and the final year of several national catch-up plans concentrated delivery in 2027.
Mechanism and resistance
National immunization programs, supported by Gavi and UNICEF, ran intensified campaigns; vaccine hesitancy and conflict-related access barriers persisted in specific districts.
Consequences
Large outbreaks became less frequent in recovering countries; residual zero-dose pockets continued to generate localized epidemics. Health-system strengthening budgets competed with other post-pandemic priorities.
End state
By the end of 2027 published WHO/UNICEF coverage estimates showed measles and DTP3 above the 2019 global level for the first time since the pandemic, although equity gaps remained.
Observable test
Official WHO/UNICEF joint reporting form estimates for 2027 showing the coverage recovery.
Disconfirming sign
Continued global coverage below the 2019 baseline in the 2027 estimates.